Zhejiang Changming Pharmaceutical Co Ltd is a prominent manufacturer and supplier within the pharmaceutical industry, specialising in the research, development, production, and marketing of cardiovascular and other therapeutic drug-related Active Pharmaceutical Ingredients (APIs) and intermediates. Established in 1998, Changming Pharmaceutical has developed a reputation as a leading supplier of pharmaceutical-grade ACE inhibitor APIs and intermediates. Their range of leading products includes Enalapril, Maleate, Ramipril, Lisinopril, and more. The company operates from two state-of-the-art manufacturing facilities located in Zhejiang and Anhui Province, covering over 210,000 square meters and employing more than 300 dedicated staff members. Changming Pharmaceutical is certified with Chinese GMP, ISO 9001:2000, ISO14001:2004, OHSAS18001, and has passed USFDA and EU inspections.

Services include:
- Regulatory Services
- APIs (Active Pharmaceutical Ingredients)
- Intermediates
- Fine Chemicals

Zhejiang Changming Pharmaceutical Co Ltd continues to excel in providing high-quality pharmaceutical products and services to clients globally. For more information, please visit cmpharm.com.